Медицинская литература. Новинки

 

 

 

 

 

 

Длительная регионарная артериальная инфузия в лечении острого панкреатита

Вы можете загрузить полный текст статьи в формате pdf

Представлен обзор литературы по использованию длительной регионарной артериальной инфузии ингибиторов протеаз и антибактериальных препаратов с целью лечения острого панкреатита. Описана методика введения препаратов и результаты рандомизированного клинического исследования.

Ключевые слова:
острый панкреатит, длительная регионарная инфузионная терапия, acute pancreatitis, continuous regional arterial infusion

Литература:
1.Затевахин И.И., Цициашвили М.Ш., Будурова М.Д. Оценка объема органных и внеорганных поражений при остром деструктивном панкреатите и ее влияние на летальность. Анналы хирургии. 2002; 1: 35-42.
2.Савельев В.С., Филимонов М.И., Бурневич С.З. Панкреонекрозы. М.: Медицинское информационное агентство, 2008; 264 с.
3.Биленко М.В. Ишемические и реперфузионные повреждения органов (молекулярные механизмы, пути предупреждения и лечения): монография. М.: Медицина, 1989; 369 с.
4.Moens A.L., Claeys M.J., Timmermans J.P., Vrints C.J. Myocardialischemia/reperfusion - injury, a clinical view on a complex pathophysiological process. Int. J. Cardiol. 2005; 100 (2): 179-190.
5.Entman M.L., Smith W.C. Postreperfusoin inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc. Res. 1994; 28 (9): 1301-1311.
6.Кузнецов Г.Л. Регионарная внутриартериальная лекарственная терапия в комплексном лечении панкреонекрозов: дис. … канд. мед. наук. Барнаул, 2004; 131 с.
7.Amendt K. PGEI and other prostaglandins in the treatment of intermittent claudication: a meta-analysis. Angiology. 2005; 56 (4): 409-415.
8.Mikami Y., Takeda K., Omura N., Abe H., Fukuyama S., Motoi F., Egawa S., Sunamura M., Matsuno S. New strategy for аcute necrotizing pancreatitis: Continuous regional arterial Infusion (CRAI) therapy. Rosz. Acad. Med. Bialymsts. 2005; 50: 101-105.
9.Hirata K., Mayumi T., Ohtsuki M., Matsuno S., Takada T. Clinical guideline of acute pancreatitis based on evidences. Nippon Shokakibyo Gakkai Zasshi. 2003; 100: 965-973.
10.Hayashi J., Kawarada Y., Isaji S., Yokoi H., Higashiguchi T. Therapeutic effects of continuous intraarterial antibiotic infusion in preventing pancreatic infection in experimental acute necrotizing pancreatitis. Pancreas. 1996; 13 (2): 184-192.
11.Takeda K., Yamauchi J., Shibuya K., Sunamura M., Mikami Y., Matsuno S. Benefit of continuous regional arterial infusion of protease inhibitor and antibiotic in the management of acute necrotizing pancreatitis. Pancreatology. 2001; 1 (6): 668-673.
12.Mikami Y., Takeda K., Matsuda K., Qiu-Feng H., Fukuyama S., Egawa S., Sunamura M., Matsuno S. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas. 2005; 30 (3): 248-253.
13.Wada K., Takada T., Hivata K., Mayumi T., Yoshida M., Yokoe M., Kiriyama S., Hirota M., Kimura Y., Takeda K., Arata S., Hirota M., Sekimoto M., Isaji S., Takeyama Y., Gabata T., Kitamura N., Amano H. Treatment strategy for acute pancreatitis. J. Hepatobiliary Pancreat. Sci. 2010; 17 (1): 79-86.
14.Buchler M., Malfertheiner P., Uhl W., Scholmerich J., Stockmann F., Adler G., Gaus W., Pancreatitis Study Group. Gastroenterology. 1993; 104 (4): 1165-1170.
15.Yang C.Y., Chang-Chien C.S., Liaw Y.F. Controlled trial of protease inhibitor gabexate mesilate (FOY) in the treatment of acute pancreatitis. Pancreas. 1987; 2 (6): 698-700.
16.Banks P.A. Practice guidelines in acute pancreatitis. Am. J. Gastroenterol. 1997; 92 (3): 377-386.
17.Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut. 2005; 54 (Suppl. 3): 1-9.
18.Chen H.M., Chen J.C., Hwang T.L., Jan Y.Y., Chen M.F. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology. 2000; 47 (34): 1147-1150.
19.Freise J., Melzer P., Schmidt F.W., Horbach L. Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients. Z. Gastroenterol. 1986; 24: 200-211.
20.Andriulli A., Leandro G., Clemente R., Festa V., Caruso N., Annese V., Lezzi G., Lichino E., Bruno F., Perri F. Metaanalysis of somatostatin, octreotide and gabexate mesilate in therapy of acute pancreatitis. Aliment Pharmacol. Ther. 1998; 12 (3): 237-245.
21.Takeda K., Matsuno S., Sunamura M., Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotic in acute necrotizing pancreatitis. Am. J. Surg. 1996; 171 (4): 394-398.
22.Лубянский В.Г., Арутюнян Г.А., Алиев А.Р., Жаринов А.И. Коррекция регионарного кровообращения в комплексном лечении больных острым панкреатитом. Анналы хирургической гепатологии. 2014; 19 (3): 86-91.
23.Watanabe S. Acute pancreatitis: overview of medical aspects. Pancreas. 1998; 16 (3): 307-311.
24.Takeuchi T., Takebe T., Sato T. Clinical evaluation of FUT - 175 (nafamostatmesilate) on pancreatitis. A double-blind controlled study with gabexatemesilate. Digest. Med. 1984; 1: 255-270.
25.Yamamura H., Tamakuma S., Nakashima M. Clinical evaluation of MR-20 on shock. A double-blind controlled study with aprotinin. J. Clin. Exp. Med. 1984; 129 (69): 730-738.
26.Tsukagoshi S. Pharmacokinetics studies of nafamostatmesilate (FUT), a synthetis protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis and as an anticoagulant in extracorporeal circulation. Jpn. J. Cancer Chemother. 2000; 27 (1): 767-774.
27.Yamauchi J., Takeda K., Shibuya K., Sunamura M., Matsuno S. Continuous regional application of protease inhibitor in the treatment of acute pancreatitis. An experimental study using closed duodenal obstruction model in dogs. Pancreatology. 2001; 1 (6): 662-667.
28.Mikami Y., Takeda K., Matsuda K., Qiu-Feng H., Fukuyama S., Egawa S., Sunamura M., Matsuno S. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas. 2005; 30 (3): 248-253.
29.Buchler M., Malfertheiner P., Uhl W., Scholmerich J., Stockmann F., Adler G., Gaus W., Rolle K., Beger H.G. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology. 1993; 104 (4): 1165-1170.
30.Pederzoli P., Bassi C., Vesentiti S., Campedelli A. A randomized multicenter clinical trail of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg. Gynecol. Obstet. 1993; 176 (5): 480-483.
31.Buchler M., Malfertheiner P., Friess H., Isenmann R., Vanek E., Grimm H., Schlegel P., Friess T., Beger H.G. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992; 103 (4): 1902-1908.
32.Imaizumi H., Kida M., Nishimaki H., Okuno J., Kataoka Y., Kida Y., Soma K., Saigenji K. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. Pancreas. 2004; 28 (4): 369-373.
33.Takeda K., Yamauchi J., Shibuya K., Sunamura M., Mikami Y., Matsuno S. Benefit of continuous regional arterial infusion of protease inhibitor and antibiotic in the management of acute necrotizing pancreatitis. Pancreatology. 2001; 1 (6): 668-673.
34.Takeda K., Matsuno S., Ogawa M., Watanabe S., Atomi Y. Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan. Hepatobiliary Pancreat. Surg. 2001; 8 (3): 216-220.
35.Takeda K., Matsuno S., Sunamura M., Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotic in acute necrotizing pancreatitis. Am. J. Surg. 1996; 171 (4): 394-398.
36.Hirota M., Inoue K., Kimura Y., Mizumoto T., Kuwata K., Ohmuraya M., Ishiko T., Beppu T., Ogawa M. Non-occlusive mesenteric ischemia and its associated intestinal gangrene in acute pancreatitis. Pancreatology. 2003; 3 (4): 316-322.
37.Takeda K., Mikami Y., Fukuyama S., Egawa S., Sunamura M., Ishibashi T., Sato A., Masamune A., Matsuno S. Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis. Pancreas. 2005; 30 (1): 40-49.
38.Horibe M., Sasaki M., Sanui M., Sugiyama D., Iwasaki E., Yamagishi Y., Sawano H., Goto T., Ikeura T., Hamada T., Oda T., Yasuda H., Shinomiya W., Miyazaki D., Hirose K., Kitamura K., Chiba N., Ozaki T., Yamashita T., Koinuma T., Oshima T., Yamamoto T., Hirota M., Moriya T., Shirai K., Mayumi T., Kanai T. Continuous regional arterial infusion of protease inhibitors has no efficacy in the treatment of severe acute pancreatitis. Pancreas. 2017; 46 (4): 510-517. DOI: 10.1097/MPA.0000000000000775.

Continuous Regional Arterial Infusion in Acute Pancreatitis Management (Review)

It is a literature review for the use of continuous regional arterial infusion of protease inhibitors and antibacterial drugs in acute pancreatitis management. The technique of drug administration and the results of randomized clinical trial are described.

Keywords:
острый панкреатит, длительная регионарная инфузионная терапия, acute pancreatitis, continuous regional arterial infusion